LINE-1 elements comprise approximately 17% of human DNA and their mobility continues to impact genome evolution. However, little is known about the types of non-transformed cells that can support LINE-1 retrotransposition. Here, we show that human embryonic stem cells express endogenous LINE-1 elements and can accommodate LINE-1 retrotransposition in vitro. The resultant retrotransposition events can occur into genes and can result in the concomitant deletion of genomic DNA at the target site. Thus, these data suggest that LINE-1 retrotransposition events may occur during early stages of human development.
INTRODUCTION
Long interspersed element-1 (LINE-1 or L1) is an abundant retrotransposon that comprises approximately 17% of human DNA (1) . The average human genome contains approximately 80 -100 retrotransposition-competent LINE-1 elements (RC-L1s) (2) . RC-L1 mobility in both germ and somatic cells has resulted in a variety of genetic disorders, including hemophilia A, muscular dystrophy and colon cancer [reviewed in (3, 4) ]. The LINE-1-encoded proteins are also responsible for the mobilization of Alu elements, certain short interspersed elements (SINEs) and the formation of processed pseudogenes, which together comprise approximately 13% of human DNA (3 -7) . Thus, LINE-1-mediated retrotransposition events are responsible for at least one billion bases in human DNA and have had a tremendous impact on human genome evolution.
Human RC-L1s are approximately 6 kb in length and contain a 5 0 -untranslated region (UTR), two non-overlapping open reading frames (ORF1 and ORF2) and a 3 0 -UTR that ends in a poly (A) tail (8) . Genetic and biochemical studies indicate that the ORF1-and ORF2-encoded proteins (ORF1p and ORF2p) exhibit a strong cis-preference and preferentially associate with their encoding RNA to form a ribonucleoprotein particle (6, 9, 10) , which is a likely retrotransposition intermediate (11, 12) . The resultant ribonucleoprotein particle is transported to the nucleus (13) where LINE-1 retrotransposition is thought to occur by a mechanism termed target-site primed reverse transcription (TPRT) (10,14 -16) . Genetic and biochemical studies indicate that conventional TPRT requires a nucleic acid chaperone activity contained within ORF1p (17, 18) as well as endonuclease and reverse transcriptase activities contained within ORF2p (15, 19) .
Although it is estimated that that up to 5% of newborns may contain a de novo L1-mediated retrotransposition event (4, 20) , relatively little is known about the developmental timing or the cell types that accommodate LINE-1 retrotransposition in humans. In vivo studies using mouse models indicate that LINE-1 expression and/or retrotransposition can occur in male and female germ cells, during early development, and in selected somatic tissues (12,21 -23) . By comparison, an in vitro retrotransposition assay has been used to demonstrate LINE-1 retrotransposition in a variety of human and rodent transformed cell lines (19,24 -28) , in rat neuronal progenitor cells (23) and at a relatively low level in primary human fibroblasts (13, 29) . Here, we demonstrate that human embryonic stem (hES) cells can accommodate the retrotransposition of engineered LINE-1 elements in vitro. These data suggest that LINE-1 retrotransposition events may occur at early stages in human embryogenesis and that some individuals in the population may be genetic mosaics with respect to their LINE-1 content. 
RESULTS AND DISCUSSION
To analyze if undifferentiated hES cells express endogenous LINE-1 elements, we isolated ribonucleoprotein particles (RNPs) from federally approved H9 hES cells (30) . Endogenous ORF1p and LINE-1 mRNA were present in those RNPs, and sequencing of the LINE-1 RT -PCR products showed that the RNAs were derived from both active and inactive L1 subfamilies (e.g. L1HS, L1PA2, L1PA3, L1PA4, L1PA6 and L1PA7; Fig. 1A ), which is consistent with results from similar experiments conducted with human teratocarcinoma cells (Fig. 1A) (31) . Similar RNA expression data were also (19, 21) . Cartoons of the unspliced (1243 bp using the EGFP indicator cassette or 1361 bp using the NEO indicator cassette) and spliced (342 bp using the EGFP indicator cassette or 468 bp using the NEO indicator cassette) products are shown beside the gels. Controls for the spliced and unspliced products are indicated by Cþ in the top gel and 2intron (2I) and þintron (þI) in the bottom gel.
obtained from BG01, H1, H7, HSF-6 cells and from a nonfederally approved cell line (Cyth25; Supplementary Material, Fig. S1A ).
To determine if a LINE-1 element could retrotranspose in hES cells, we transfected undifferentiated hES cells with either a human RC-L1 (2) whose expression was driven from its native 5 0 -UTR or a synthetic mouse RC-L1 (27) whose expression was augmented by the cytomegalovirus immediate early (CMV) promoter. These RC-L1s were tagged with a retrotransposition indicator cassette in their respective 3 0 -UTRs, which consists of a backward copy of a reporter gene (REP) containing its own promoter and polyadenylation signal (Fig. 1B) (19, 21) . The reporter gene is also interrupted by an intron in the same transcriptional orientation as the RC-L1. This arrangement ensures that the reporter cassette will only become activated if spliced RC-L1 mRNA undergoes a successful round of retrotransposition (Fig. 1B) .
RC-L1s containing either an enhanced green fluorescent protein (EGFP) or neomycin phosphotransferase (NEO) retrotransposition indicator cassette were transfected into four different hES cell lines (H1, H9, BG01 and Cyth25; Fig. 1C) . A low level of retrotransposition was reproducibly observed in early and late passage hES cells transfected with the RC-L1s. However, we never detected retrotransposition from mutant LINE-1 constructs that contain either a missense mutation in the reverse transcriptase active site (JM101/L1.3/ D702A) or two missense mutations in the ORF1 RNA-binding domain (JM111/L1 RP /RR261-262AA). As expected, PCR experiments conducted using genomic DNA templates isolated from hES cell lines containing a retrotransposition event confirmed the precise splicing of the intron from the retrotransposition indicator cassette (Fig. 1D) .
Additional control experiments demonstrated that the G418-resistant cell lines express both OCT4 and TRA1 -60 (30) ( Fig Together, these data demonstrate that an engineered LINE-1, whose expression is driven by its own promoter, is able to retrotranspose in undifferentiated hES cells in vitro.
We next characterized seven retrotransposition events from hES cells. Insertion (A) was generated from a synthetic mouse LINE-1 element whose expression was driven from a heterologous CMV promoter, whereas insertions (B -G) were generated from two different human RC-L1s [LRE3 (insertions B -F) or L1 RP (insertion G)] whose expression was driven from their endogenous 5 0 -UTR (Fig. 3 ). The analysis of the pre-and post-integration sites revealed structural hallmarks of LINE-1 retrotransposition (Fig. 3 , A -G, Table 1 ; Supplementary Material, Fig. S2 ). Each insertion was 5 0 -truncated and ended in a poly (A) tail. Five of seven events were flanked by a variable sized target site duplication that ranged in size from 3 to 16 bp, and at least six of the events integrated into a sequence that closely resembles a consensus LINE-1 endonuclease cleavage site (15,32) (5 0 -TTTT/A, Table 1 ; Supplementary Material, Fig. S2 ). Three insertions occurred into the introns of known ( Fig. 3; insertions B and F) or hypothetical genes (Fig. 3 ; insertion G). Two other events were associated with genomic deletions at the target site of either 3 , insertions E and F). Interestingly, insertions C and D occurred into a similar region of genomic DNA and were only separated by 344 bp (Fig. 3) , suggesting that this sequence on chromosome 15 may be a preferred site of LINE-1 integration and/or expression of the retrotransposition indicator cassette in hES cells. Together, these results are consistent with previously published studies using transformed human cell lines and/or rat neural progenitor cells (19, 23, 32) . Our data indicate that genetically engineered human and mouse LINE-1 elements can retrotranspose in hES cells. Technical issues (e.g. the difficulty in transfecting hES cells (,10%), their low cloning efficiency (,1%) and their tendency to differentiate) make it difficult to precisely determine the LINE-1 retrotransposition efficiency at this time; however, it appears to be at least an order of magnitude lower than what has been observed in transformed cell lines (19,24 -28) . In addition to the technical challenges involved in working with hES cells, we can envision at least two reasons to account for this apparently lower retrotransposition efficiency. First, LINE-1 retrotransposition events in hES cells may integrate into non-permissive chromatin contexts or may be subject to epigenetic silencing leading to the inactivation of the reporter cassette either during or soon after retrotransposition (23) . Secondly, hES cells may express endogenous proteins that serve to protect the genome from de novo retrotransposition events. Clearly, additional studies and technical advances in the manipulation of hES cells are necessary to address these interesting possibilities.
In sum, our results show that endogenous LINE-1 elements are expressed in hES cells, that retrotransposition events derived from engineered L1s can occur into genes, and that some of those insertions are accompanied by concomitant deletions of target site nucleotides. Although in vitro experiments conducted in isolated hES cells do not fully reflect the environment in utero, the available data suggest that LINE-1 retrotransposition events may occur at early stages in human embryogenesis and that some individuals in the population may be genetically mosaic with respect to their LINE-1 content. Indeed, the accompanying paper by van den Hurk et al. provides compelling genetic experiment that support our findings. Thus, in addition to the previously described mechanisms of genome instability in hES cells (33) , we speculate that LINE-1 retrotransposition could contribute to hES genome fluidity and variability.
MATERIALS AND METHODS

Culturing conditions
The following hES cell lines [H1, H7, H9 (30), BG01 (34), HSF-6 (35) and Cyth 25 (36,37)] (Cythera Inc., San Diego, USA) were grown in gelatin-coated plates on mouse embryonic fibroblasts (MEFs, passage 3) derived from CF-1 mice. MEFs were mitotically inactivated by g-irradiation with a 2100 Cesium source indicator with 3000-3200 rads, and then were seeded onto gelatin-coated plates (Sigma) at a density of 25 000 cells/cm 2 ; MEFs were routinely used within 3 days after being irradiated. Culture medium for hES cells consists of: DMEM F12 (Invitrogen) supplemented with 4 ng/ml of b-FGF (fibroblast growth factor), 20% KO serum replacement, 1 mM L-glutamine, 50 mM b-mercaptoethanol and 0.1 mM nonessential amino acids. Cells were passaged by manual dissection every 4 days and the medium was replaced daily. Frozen stocks of karyotyped hES cells were used for approximately 30 passages.
Plasmid construction
Cloning strategies are available upon request. All plasmids used in this study contain the indicated fragments of L1 DNA cloned into pCEP4 (Invitrogen) or pBSKS-II (Stratagene).
cep99-gfp-L1RP-hygro has been described previously (38) . It contains an 8.7-kb NotI-BamHI fragment containing a fulllength L1 RP element (39) , and the EGFP retrotransposition indicator cassette. It is cloned in a modified version of pCEP that lacks the CMV promoter.
cep99-gfp-JM111-hygro is a derivative of cep99-gfp-L1 RP-hygro that contains the double missense mutation RR261-262AA in ORF1p (38) .
ks-99-gfp-LRE3-sv(þ) contains an 8.9-kb NotI-SalI fragment containing a full-length LRE3 element (40) , the EGFP retrotransposition indicator cassette and the SV40 late ks-99-gfp-JM111-sv(þ) contains an 8.9-kb NotI-SalI fragment containing a full-length L1RP element that contains the double missense mutation RR261-262AA in ORF1p (38) , the EGFP retrotransposition indicator cassette and the SV40 late polyadenylation signal. It is cloned in pBSKS-II. pcepL1SM contains a codon optimized full-length mouse element (derived from L1 spa ) containing the mneoI indicator cassette (27) . The plasmid was a kind gift from Dr Jef Boeke.
ks-101-LRE3-sv(þ) contains an 8.7-kb NotI-SalI fragment containing a full-length LRE3 element, the NEO retrotransposition indicator cassette and the SV40 late polyadenylation signal. It is cloned in pBSKS-II. Column 1, the name of the cell line; column 2, the chromosomal location of the insertion; column 3, sequence characteristics of the insertion; column 4, length of the insertion (excluding the retrotransposition indicator cassette); column 5, the sequence of the LINE-1 endonuclease bottom strand cleavage site; column 6, target site alterations associated with retrotransposition; column 7, length of the poly (A) tail. N.A., not analyzed. Please see Supplementary Material, Figure S2 for additional details.
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ks-105-L1.3-sv(þ) contains an 8.7-kb NotI-SalI fragment containing a full-length L1.3 element that contains a missense mutation in the RT active site (D702A) (25) , the NEO indicator cassette and the SV40 late polyadenylation signal. It is cloned in pBSKS-II.
DNA preparation
LINE-1 plasmid DNAs were purified on Qiagen midi prep columns (Qiagen). DNAs for transfection experiments were checked for superhelicity by electrophoresis on 0.7% agarose-ethidium bromide gels. Only highly supercoiled preparations of DNA (.90%) were used for transfection. BAC clones were purchased from BACPAC Resources (Children's Hospital and Research Center, Oakland, CA, USA). BAC DNAs were purified on Qiagen midi prep columns according to the manufacturer's protocol.
RT -PCR analysis
Total RNA was extracted with Trizol (Invitrogen) and treated with RNase-free RQ-1 DNase I (Promega). RNA (1 mg) was reverse-transcribed with MMLV RT (25 U, Promega) primed with Oligo dT 12 -18 (Invitrogen) for 1 h at 428C. High fidelity Taq from Roche was used in the PCR reactions. PCR amplifications were as follows: one cycle of 958C for 2 min, followed by 30 cycles of 948C for 30 s, annealing at the oligonucleotide melting temperature (Tm-58C; Supplementary Material, Table S1) for 30 s and 728C for 1 min, followed by a final extension of 728C for 10 min. Oligonucleotide sequence and their melting temperatures (Tm-58C) are listed in Supplementary Material, Table S1 .
Immunocytochemistry hES cells grown on MEFs or matrigel-coated dishes were fixed with paraformaldehyde (2% in PBS 1Â) for at least 1h at 48C. Immunocytochemistry was performed as previously described (41) . The Oct4 goat polyclonal antibody (Santa Cruz) was used at a 1/100 dilution. The Tra1 -60 mouse monoclonal antibody (Chemicon) was used at a 1/50 dilution. Secondary antibodies were purchased from Jackson ImmunoResearch, and were used at a 1/200 dilution. Hoechst was purchased from Sigma and used at a 1/10 000 dilution.
Preparation of whole cell lysates, sucrose cushions and western blot analysis
Approximately 8Â10
6 hES cells were manually harvested, washed with 1Â PBS and lysed with 1ml of 1.5 mM KCl, 2.5 mM MgCl 2 , 5 mM Tris -HCl pH 7.4, 1% deoxycholic acid, 1% Triton X-100, 1Â Complete Mini EDTA-free protease inhibitor cocktail (Roche). After a 10-min incubation on ice, the cell debris was removed by centrifugation at 3000g at 48C for 5 min. A sucrose cushion was prepared with 8.5 and 17% w/v sucrose in 80 mM NaCl, 5 mM MgCl 2 , 20 mM Tris-HCl pH 7.5, 1 mM DTT, 1Â Complete Mini EDTA-free protease inhibitor cocktail. Lysates were spun at 178 000 g at 48C for 2 h using a Sorvall SW-41 rotor. After centrifugation, the pelleted material was resuspended in 50 ml of purified water with 1Â Complete Mini EDTA-free protease inhibitor cocktail (Roche). Total protein concentration was determined by Bradford assay (BioRad) according to the manufacturer's instructions, and 11 mg of sample were loaded on a pre-cast 10% SDS-PAGE gel (BioRad). Rabbit polyclonal anti-ORF1 antibody (a generous gift from Dr Thomas Fanning) was used at a 1/10 000 dilution, followed by a goat anti-rabbit HRP conjugate secondary antibody at a 1/20 000 dilution (Abcam).
hES cell transfection and retrotransposition assay Cells were transfected with either FuGene 6 (Roche) as previously described (42) or by Nucleofection using the V-Kit solution (Amaxa) and the A-23 program following manufacturer's instructions. Transient transfection using LINE-1 elements containing the EGFP retrotransposition indicator cassette in a pBSKS (2) backbone were performed with approximately 2 -4 Â 10 6 hES cells, which were then grown on plates containing irradiated MEFs. Cells were re-fed daily, and the appearance of EGFP (þ) cells was monitored using florescence microscopy.
hES cells transfected with LINE-1 elements containing the EGFP retrotransposition indicator cassette on a pCEP backbone (approximately 2 Â 10 6 cells) were transfected and seeded on Hygro-resistant MEF feeder cells. Two days after transfection 200 mg/ml of hygromicin was added to the media, and cells selected for 6 days. Sections of EGFP (þ) hES colonies were manually excised and transferred to fresh plates. Cell lines were established by subsequent manual passage on MEF containing plates.
In the NEO-based retrotransposition assay, approximately 2Â10 6 hES cells were transfected and seeded onto Matrigelcoated plates (Becton, Dickinson and Company). Cells were re-fed daily with MEF-conditioned media [DMEM F12 (Invitrogen) supplemented with 4 ng/ml b-FGF, 20% KO serum replacement, 1 mM L-glutamine, 50 mM b-mercaptoethanol and 0.1 mM non-essential amino acids] supplemented with an additional 40 ng/ml of b-FGF (Invitrogen) (43, 44) . Four days after transfection, hES cell were selected with 50 mg/ml of geneticin (G-418, Invitrogen) for 1 week and with 100 mg/ml of G418 the following week (42) . After 14 days of selection, G418 resistant colonies were manually passaged to individual wells of a 12-well culture dish containing irradiated MEFs. We established the cell lines by manually passaging the resultant cell lines on the MEF-containing plates. Eleven hES cell lines containing a LINE-1 retrotransposition event were originally established. Nine of these cell lines were successfully cryopreserved using the CRYOLOGICS CL-8000 rate controlled freezer (Villa and Smith, personal communication). 
Differentiation of hES cells into embryoid bodies
Insertion characterization by inverse PCR
Genomic DNA from hES cell lines containing a LINE-1 insertion was purified using the Blood Midi Kit from Qiagen. Five micrograms of purified genomic DNA were digested overnight with either SspI or HindIII, and self-ligated in a final volume of 1 ml with 3200 U of T4 DNA ligase (NEB) for at least 16 h at 168C. Ligated DNA was phenol-extracted, ethanolprecipitated and re-dissolved in 40 ml of purified water. Two to four microlitres were subjected to inverse PCR as previously described (6, 23) . The resultant products were cloned in Topo-XL (Invitrogen) and sequenced. When needed, the empty and filled sites were recovered from the genomic DNA by performing conventional PCR reactions using long template DNA polymerase (Roche). DNA sequence analysis was performed at UCSC genome browser (http://genome. ucsc.edu/cgi-bin/hgBlat, May 2004 assembly) (45) . For analysis of the pre-integration site of insertion (E) in Figure 2 and Supplementary Material, Figure S2 , PCR reactions were performed using 0.2 mg of BAC DNA as a template using highfidelity expand DNA polymerase (Roche), using the primers noted in Supplementary Material, Table S1 .
